Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2017, Article ID 3587309, 21 pages
https://doi.org/10.1155/2017/3587309
Review Article

Intelligent Techniques Using Molecular Data Analysis in Leukaemia: An Opportunity for Personalized Medicine Support System

1School of Computer Science, University of Adelaide, Adelaide, SA, Australia
2Department of Computer Science, King Abdulaziz University, Jeddah, Saudi Arabia
3School of Molecular and Biomedical Science, University of Adelaide, Adelaide, SA, Australia
4Oncology Centre, Section of Hematology, HSCT, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia

Correspondence should be addressed to Haneen Banjar; as.ude.uak@rajnabrh

Received 5 April 2017; Revised 12 June 2017; Accepted 15 June 2017; Published 25 July 2017

Academic Editor: Junya Kuroda

Copyright © 2017 Haneen Banjar et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. K. K. Jain, Basics of Personalized Medicine Textbook of Personalized Medicine, Springer, New York, NY, USA, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. S. J. Swierzewski, Leukemia Basics: Remedy Health Media; 1999, http://www.healthcommunities.com/leukemia/types.shtml.
  3. G. S. Ginsburg and H. F. Willard, “Genomic and personalized medicine: foundations and applications,” Translational Research, vol. 154, no. 6, pp. 277–287, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. J. Cortes and H. Kantarjian, “How I treat newly diagnosed chronic phase CML,” Blood, vol. 120, no. 7, pp. 1390–1397, 2012. View at Publisher · View at Google Scholar · View at Scopus
  5. I. Kouris, C. Tsirmpas, S. G. Mougiakakou, D. Iliopoulou, and D. Koutsouris, “E-health towards ecumenical framework for personalized medicine via Decision Support System,” in Proceedings of the 2010 32nd Annual International Conference of the IEEE Engineering in Medicine and Biology Society, EMBC'10, pp. 2881–2885, September 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. C. L. Overby, P. Tarczy-Hornoch, I. J. Kalet et al., “Developing a prototype system for integrating pharmacogenomics findings into clinical practice,” Journal of Personalized Medicine, vol. 2, no. 4, pp. 241–256, 2012. View at Publisher · View at Google Scholar
  7. N. Douali and M.-C. Jaulent, “Genomic and personalized medicine decision support system,” in Proceedings of the 1st International Conference on Complex Systems, ICCS 2012, November 2012. View at Publisher · View at Google Scholar · View at Scopus
  8. S. G. Mougiakakou, I. K. Valavanis, G. Karkalis, S. Marinos, K. A. Grimaldi, and K. S. Nikita, “An integrated web-based platform for the provision of personalized advice in people at high risk for CVD,” in Proceedings of the 9th International Conference on Information Technology and Applications in Biomedicine, ITAB 2009, November 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. D. C. Klonoff, “Personalized medicine for diabetes,” Journal of Diabetes Science and Technology, vol. 2, no. 3, pp. 335–341, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. K. Zarkogianni, S. G. Mougiakakou, A. Prountzou, A. Vazeou, C. S. Bartsocas, and K. S. Nikita, “An insulin infusion advisory system for type 1 diabetes patients based on non-linear model predictive control methods,” in Proceedings of the Engineering in Medicine and Biology Society, 2007 EMBS 2007 29th Annual International Conference of the IEEE, pp. 22–26, 2007. View at Scopus
  11. Y. Goletsis, T. P. Exarchos, N. Giannakeas, and D. I. Fotiadis, “Intelligent patient profiling for diagnosis, staging and treatment selection in colon cancer,” in Proceedings of the 8th IEEE International Conference on BioInformatics and BioEngineering, BIBE 2008, October 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. A. Kulkarni, B. S. C. Naveen Kumar, V. Ravi, and U. S. Murthy, “Colon cancer prediction with genetics profiles using evolutionary techniques,” Expert Systems with Applications, vol. 38, no. 3, pp. 2752–2757, 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. H. Moon, H. Ahn, R. L. Kodell, S. Baek, C.-J. Lin, and J. J. Chen, “Ensemble methods for classification of patients for personalized medicine with high-dimensional data,” Artificial Intelligence in Medicine, vol. 41, no. 3, pp. 197–207, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. V. J. Weigman Jr., High Level Integration of Genomic Data for Improving Prediction, Prognostication and Classification of Breast Tumors. Proquest Dissertations and Theses, University of North Carolina, Chapel Hill, NC, USA, 2010.
  15. M. Ture, F. Tokatli, and I. Kurt Omurlu, “The comparisons of prognostic indexes using data mining techniques and Cox regression analysis in the breast cancer data,” Expert Systems with Applications, vol. 36, no. 4, pp. 8247–8254, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. M. U. Khan, J. P. Choi, H. Shin, and M. Kim, “Predicting breast cancer survivability using fuzzy decision trees for personalized healthcare,” in Proceedings of the 30th Annual International Conference of the IEEE Engineering in Medicine and Biology Society, EMBS'08, pp. 5148–5151, August 2008. View at Scopus
  17. S. Lekkas and L. Mikhailov, Breast Cancer Diagnosis Based on Evolvable Fuzzy Classifiers and Feature Selection. Applications and Innovations in Intelligent Systems XVI, Springer, London, UK, 2009.
  18. D. Lavanya and K. Usha Rani, “Ensemble Decision Making System for Breast Cancer Data,” International Journal of Computer Applications, vol. 51, no. 17, pp. 19–23, 2012. View at Publisher · View at Google Scholar
  19. D. Lavanya and KU. Raniv, “Analysis of feature selection with classfication: breast cancer datasets,” Indian Journal of Computer Science and Engineering (IJCSE), vol. 2, no. 5, p. 763, 2011. View at Google Scholar
  20. A. Keleş, A. Keleş, and U. Yavuz, “Expert system based on neuro-fuzzy rules for diagnosis breast cancer,” Expert Systems with Applications, vol. 38, no. 5, pp. 5719–5726, 2011. View at Publisher · View at Google Scholar · View at Scopus
  21. B. Jahn, N. Muhlberger, J. Wurm, and U. Siebert, “Decision-analytic models for breast cancer: Do currently published models meet the requirements of personalized medicine?” in Proceedings of the 2008 Winter Simulation Conference (WSC), pp. 2946–2946, Miami, FL, USA, December 2008. View at Publisher · View at Google Scholar
  22. J. M. Garibaldi, S.-M. Zhou, X.-Y. Wang, R. I. John, and I. O. Ellis, “Incorporation of expert variability into breast cancer treatment recommendation in designing clinical protocol guided fuzzy rule system models,” Journal of Biomedical Informatics, vol. 45, no. 3, pp. 447–459, 2012. View at Publisher · View at Google Scholar · View at Scopus
  23. D. Delen, G. Walker, and A. Kadam, “Predicting breast cancer survivability: a comparison of three data mining methods,” Artificial Intelligence in Medicine, vol. 34, no. 2, pp. 113–127, 2005. View at Publisher · View at Google Scholar · View at Scopus
  24. C. Chen, S.-R. Sun, Y.-P. Gong et al., “Quantum dots-based molecular classification of breast cancer by quantitative spectroanalysis of hormone receptors and HER2,” Biomaterials, vol. 32, no. 30, pp. 7592–7599, 2011. View at Publisher · View at Google Scholar · View at Scopus
  25. M. Arora and D. Tagra, “Neuro-fuzzy expert system for breast cancer diagnosis,” in Proceedings of the 2012 International Conference on Advances in Computing, Communications and Informatics, ICACCI 2012, pp. 979–985, August 2012. View at Publisher · View at Google Scholar · View at Scopus
  26. A. Ali, A. Tufail, U. Khan, and M. Kim, “A survey of prediction models for breast cancer survivability,” in Proceedings of the 2nd International Conference on Interaction Sciences: Information Technology, Culture and Human, ICIS 2009, pp. 1259–1262, November 2009. View at Publisher · View at Google Scholar · View at Scopus
  27. A. Ali, U. Khan, A. Tufail, and M. Kim, “Analyzing potential of SVM based classifiers for intelligent and less invasive breast cancer prognosis,” in Proceedings of the 2nd International Conference on Computer Engineering and Applications, ICCEA 2010, pp. 313–319, March 2010. View at Publisher · View at Google Scholar · View at Scopus
  28. E. A. Rakha, D. Soria, A. R. Green et al., “Nottingham prognostic index plus (NPI+): A modern clinical decision making tool in breast cancer,” British Journal of Cancer, vol. 110, no. 7, pp. 1688–1697, 2014. View at Publisher · View at Google Scholar · View at Scopus
  29. K. Nagasaki and Y. Miki, “Molecular prediction of the therapeutic response to neoadjuvant chemotherapy in breast cancer,” Breast Cancer, vol. 15, no. 2, pp. 117–120, 2008. View at Publisher · View at Google Scholar · View at Scopus
  30. T. Kempowsky-Hamon, C. Valle, M. Lacroix-Triki et al., “Fuzzy logic selection as a new reliable tool to identify molecular grade signatures in breast cancer—the INNODIAG study,” BMC Medical Genomics, vol. 8, no. 1, article 3, 2015. View at Publisher · View at Google Scholar · View at Scopus
  31. Arsene CTC, Lisboa PJG. Chapter 8 - Artificial Neural Networks Used in the Survival Analysis of Breast Cancer Patients: A Node-Negative Study. In: Outcome Prediction in Cancer [Internet]. Amsterdam: Elsevier; [191-239], http://www.sciencedirect.com/science/article/pii/B9780444528551500106.
  32. C. Voichita, Towards Personalized Medicine Using Systems Biology and Machine Learning, Wayne State University Dissertations, Detroit, MI, USA, 2013.
  33. D.-C. Kim, X. Wang, C.-R. Yang, and J. X. Gao, “A framework for personalized medicine: prediction of drug sensitivity in cancer by proteomic profiling,” Proteome Science, vol. 10, no. 1, 2012. View at Google Scholar
  34. D.-C. Kim, J. Gao, X. Wang, and C.-R. Yang, “A framework for personalized medicine with reverse phase protein array and drug sensitivity,” in Proceedings of the 2011 IEEE International Conference on Bioinformatics and Biomedicine, BIBM 2011, pp. 426–429, November 2011. View at Publisher · View at Google Scholar · View at Scopus
  35. P. K. Anooj, “Clinical decision support system: risk level prediction of heart disease using weighted fuzzy rules,” Journal of King Saud University—Computer and Information Sciences, vol. 24, no. 1, pp. 27–40, 2012. View at Publisher · View at Google Scholar
  36. A. M. Honka, M. J. van Gils, and J. Parkka, “A personalized approach for predicting the effect of aerobic exercise on blood pressure using a fuzzy inference system,” in Proceedings of the Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC '11), pp. 8299–8302, Boston, Mass, USA, August 2011. View at Publisher · View at Google Scholar
  37. H. Michael and M. Crawford, “Individualized medicine by biomarkers,” Clinical Cardiology Alert, vol. 302, pp. 49–57, 2009. View at Google Scholar
  38. B. S. Shastry, “Pharmacogenetics and the concept of individualized medicine,” Pharmacogenomics Journal, vol. 6, no. 1, pp. 16–21, 2006. View at Publisher · View at Google Scholar · View at Scopus
  39. GLIVEC Tablets – Summary of Product Characteristics (SPC): electronic Medicines Compendium; 2001, http://www.medicines.org.uk/emc/medicine/15014/SPC/GLIVEC+Tablets/.
  40. M. J. Grant and A. Booth, “A typology of reviews: an analysis of 14 review types and associated methodologies,” Health Information & Libraries Journal, vol. 26, no. 2, pp. 91–108, 2009. View at Publisher · View at Google Scholar · View at Scopus
  41. Cancer Program Legacy Publication Resources, http://www.broadinstitute.org/cgi-bin/cancer/datasets.cgi.
  42. C. K. Yoo and K. V. Gernaey, “Classification and diagnostic output prediction of cancer using gene expression profiling and supervised machine learning algorithms,” Journal of Chemical Engineering of Japan, vol. 41, no. 9, pp. 898–914, 2008. View at Publisher · View at Google Scholar · View at Scopus
  43. M. L. Ujwal, P. Hoffman, and K. A. Marx, “A machine learning approach to pharmacological profiling of the quinone scaffold in the NCI database: A compound class enriched in those effective against melanoma and leukemia cell lines,” in Proceedings of the 7th IEEE International Conference on Bioinformatics and Bioengineering, BIBE, pp. 456–463, January 2007. View at Publisher · View at Google Scholar · View at Scopus
  44. K. A. Marx, P. O'Neil, P. Hoffman, and M. L. Ujwal, “Data Mining the NCI Cancer Cell Line Compound GI50 Values: Identifying Quinone Subtypes Effective Against Melanoma and Leukemia Cell Classes,” Journal of Chemical Information and Computer Sciences, vol. 43, no. 5, pp. 1652–1667, 2003. View at Publisher · View at Google Scholar · View at Scopus
  45. J. M. Corchado, J. F. de Paz, S. Rodríguez, and J. Bajo, “Model of experts for decision support in the diagnosis of leukemia patients,” Artificial Intelligence in Medicine, vol. 46, no. 3, pp. 179–200, 2009. View at Publisher · View at Google Scholar · View at Scopus
  46. V. G. Oehler, Y. Y. Ka, Y. E. Choi, R. E. Bumgarner, A. E. Raftery, and J. P. Radich, “The derivation of diagnostic markers of chronic myeloid leukemia progression from microarray data,” Blood, vol. 114, no. 15, pp. 3292–3298, 2009. View at Publisher · View at Google Scholar · View at Scopus
  47. K. Y. Yeung, T. A. Gooley, A. Zhang, A. E. Raftery, J. P. Radich, and V. G. Oehler, “Predicting relapse prior to transplantation in chronic myeloid leukemia by integrating expert knowledge and expression data,” Bioinformatics, vol. 28, no. 6, Article ID bts059, pp. 823–830, 2012. View at Publisher · View at Google Scholar · View at Scopus
  48. S. Savvopoulos, R. Misener, N. Panoskaltsis, E. N. Pistikopoulos, and A. Mantalaris, “A Personalized Framework for Dynamic Modeling of Disease Trajectories in Chronic Lymphocytic Leukemia,” IEEE Transactions on Biomedical Engineering, vol. 63, no. 11, pp. 2396–2404, 2016. View at Publisher · View at Google Scholar · View at Scopus
  49. L. Eisele, R. Prinz, L. Klein-Hitpass et al., “Combined PER2 and CRY1 expression predicts outcome in chronic lymphocytic leukemia,” European Journal of Haematology, vol. 83, no. 4, pp. 320–327, 2009. View at Publisher · View at Google Scholar · View at Scopus
  50. Leukaemia in Australia: The Australian Institute of Health and Welfare, http://www.aihw.gov.au/cancer/leukaemia/.
  51. J. F. Apperley, “Part I: mechanisms of resistance to imatinib in chronic myeloid leukaemia,” The Lancet Oncology, vol. 8, no. 11, pp. 1018–1029, 2007. View at Publisher · View at Google Scholar · View at Scopus
  52. D. L. White and T. P. Hughes, “Predicting the response of CML patients to tyrosine kinase inhibitor therapy,” Current Hematologic Malignancy Reports, vol. 6, no. 2, pp. 88–95, 2011. View at Publisher · View at Google Scholar · View at Scopus
  53. A. Torkaman, N. M. Charkari, and M. Aghaeipour, “A new classification approach based on cooperative game,” in Proceedings of the 2009 14th International CSI Computer Conference, CSICC 2009, pp. 458–463, October 2009. View at Publisher · View at Google Scholar · View at Scopus
  54. B. Welch and K. Kawamoto, “The Need for Clinical Decision Support Integrated with the Electronic Health Record for the Clinical Application of Whole Genome Sequencing Information,” Journal of Personalized Medicine, vol. 3, no. 4, pp. 306–325, 2013. View at Publisher · View at Google Scholar
  55. J. C. Weiss, S. Natarajan, P. L. Peissig, C. A. McCarty, and D. Page, “Machine learning for personalized medicine: Predicting primary myocardial infarction from electronic health records,” AI Magazine, vol. 33, no. 4, pp. 33–45, 2012. View at Google Scholar · View at Scopus
  56. CL. Overby, A Clinical Decision Support Model for Incorporating Pharmacogenomics Knowledge Into Electronic Health Records for Drug Therapy Individualization: A Microcosm of Personalized Medicine, University of Washington, Seattle, WA, USA, 2011.
  57. B. Hirsch and A. Abernethy, “Structured Decision-Making: Using Personalized Medicine to Improve the Value of Cancer Care,” Journal of Personalized Medicine, vol. 3, no. 1, pp. 1–13, 2013. View at Publisher · View at Google Scholar
  58. H. Yu, G. Gu, H. Liu, and J. Shen, “A framework for microarray data-based tumor diagnostic system with improving performance incrementally,” Expert Systems with Applications, vol. 37, no. 9, pp. 6682–6688, 2010. View at Publisher · View at Google Scholar · View at Scopus
  59. Global Alliance for Genomics and Health, http://genomicsandhealth.org.
  60. National Institutes of Health, U.S.: Turning Discovery Into Health, https://www.nih.gov.
  61. M. Kwiatkowska, A. S. Atkins, N. T. Ayas, and C. F. Ryan, “Integrating knowledge-driven and data-driven approaches for the derivation of clinical prediction rules,” in Proceedings of the ICMLA 2005: 4th International Conference on Machine Learning and Applications, pp. 171–176, December 2005. View at Publisher · View at Google Scholar · View at Scopus
  62. S. Saussele and M. Pfirrmann, “Clinical trials in chronic myeloid leukemia,” Current Hematologic Malignancy Reports, vol. 7, no. 2, pp. 109–115, 2012. View at Publisher · View at Google Scholar · View at Scopus
  63. M. Baccarani, F. Guilhot, R. A. Larson, S. G. O'Brien, and B. J. Druker, “Outcomes by cytogenetic and molecular response at 12 and 18 months of imatinib in patients with newly diagnosed chronic myeloid leukemia (CML) in chronic phase (CP) in the IRIS tria,” in Proceedings of the The American Society of Hematology 48th Annual Meeting and Exposition, vol. 2006, Orlando, FL, USA.
  64. M. Deininger, SG. O'Brien, F. Guilhot et al., “International Randomized Study of Interferon Vs STI571 (IRIS) 8-Year Follow up: Sustained Survival and Low Risk for Progression or Events in Patients with Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase (CML-CP) Treated with Imatinib,” in Proceedings of the Blood (ASH Annual Meeting Abstracts), 2009.
  65. W. Alexander and T. P. Hughes, “American Society of Hematology, 52nd Annual Meeting and Exposition: Nilotinib (Tasigna) found superior to imatinib (Gleevec) in chronic-phase chronic myeloid leukemia: ENESTnd update,” P and T, vol. 36, no. 2, pp. 100-101, 2011. View at Google Scholar · View at Scopus
  66. H. Kantarjian, N. P. Shah, A. Hochhaus et al., “Dasatinib versus imatinib in newly diagnosed chronic-phase chronic myeloid leukemia,” The New England Journal of Medicine, vol. 362, no. 24, pp. 2260–2270, 2010. View at Publisher · View at Google Scholar · View at Scopus
  67. T. P. Hughes, A. Hochhaus, G. Saglio et al., “ENESTnd Update: Continued Superiority of Nilotinib Versus Imatinib In Patients with Newly Diagnosed Chronic Myeloid Leukemia In Chronic Phase (CML-CP),” in Proceedings of the Blood (ASH Annual Meeting Abstracts), 2010.
  68. P. L. Alvey, N. J. Preston, and M. F. Greaves, “High performance for expert systems: II. A system for leukaemia diagnosis,” Informatics for Health and Social Care, vol. 12, no. 2, pp. 97–114, 1987. View at Publisher · View at Google Scholar · View at Scopus
  69. Y. M. Chae, Q. Park, K. S. Park, and M. Young, “Development of medical decision support system for leukemia management,” Expert Systems with Applications, vol. 15, no. 3-4, pp. 309–315, 1998. View at Publisher · View at Google Scholar · View at Scopus
  70. J. Hasford, M. Pfirrmann, R. Hehlmann et al., “Prognosis and prognostic factors for patients with chronic myeloid leukemia: Nontransplant therapy,” Seminars in Hematology, vol. 40, no. 1, pp. 4–12, 2003. View at Publisher · View at Google Scholar · View at Scopus
  71. N. Mašić, A. Gagro, S. Rabatić et al., “Decision-tree approach to the immunophenotype-based prognosis of the B- cell chronic lymphocytic leukemia,” American Journal of Hematology, vol. 59, no. 2, pp. 143–148, 1998. View at Publisher · View at Google Scholar · View at Scopus
  72. J. Hasford, M. Baccarani, V. Hoffmann et al., “Predicting complete cytogenetic response and subsequent progression-free survival in 2060 patients with CML on imatinib treatment: the EUTOS score,” Blood, vol. 114, no. 22, pp. 686–692, 2009. View at Publisher · View at Google Scholar · View at Scopus
  73. M. Breccia, F. Stagno, A. Gozzini et al., “Hammersmith score application identifies chronic myeloid leukemia patients with poor prognosis before treatment with second-generation tyrosine kinase inhibitors,” American Journal of Hematology, vol. 116, no. 21, pp. 1395-1396, 2010. View at Publisher · View at Google Scholar · View at Scopus
  74. C. N. A. M. Oldenhuis, S. F. Oosting, J. A. Gietema, and E. G. E. de Vries, “Prognostic versus predictive value of biomarkers in oncology,” European Journal of Cancer, vol. 44, no. 7, pp. 946–953, 2008. View at Publisher · View at Google Scholar · View at Scopus
  75. M. Agrawal, R. J. Garg, H. Kantarjian, and J. Cortes, “Chronic myeloid leukemia in the tyrosine kinase inhibitor era: What is the "best" therapy?” Current Oncology Reports, vol. 12, no. 5, pp. 302–313, 2010. View at Publisher · View at Google Scholar · View at Scopus
  76. F. Guilhot and J. Guilhot, “Predicting response in CML,” Blood, vol. 117, no. 6, pp. 1773-1774, 2011. View at Publisher · View at Google Scholar · View at Scopus
  77. E. Jabbour, H. Kantarjian, S. O'Brien et al., “Predictive factors for outcome and response in patients treated with second-generation tyrosine kinase inhibitors for chronic myeloid leukemia in chronic phase after imatinib failure,” Blood, vol. 117, no. 6, pp. 1822–1827, 2011. View at Publisher · View at Google Scholar · View at Scopus
  78. J. Sokal, E. Cox, M. Baccarani, and S. Tura, “Prognostic discrimination in good-risk chronic granulocytic leukemia,” Blood, vol. 63, pp. 789–799, 1984. View at Google Scholar
  79. J. Hasford, M. Pfirrmann, R. Hehlmann et al., “A new prognostic score for survival of patients with chronic myeloid leukemia treated with interferon alfa. Writing Committee for the Collaborative CML Prognostic Factors Project Group,” Journal of the National Cancer Institute, vol. 90, no. 11, pp. 850–858, 1998. View at Publisher · View at Google Scholar · View at Scopus
  80. J. Hasford, M. Baccarani, V. Hoffmann et al., “Predicting complete cytogenetic response and subsequent progression-free survival in 2060 patients with CML on imatinib treatment: the EUTOS score,” Blood, vol. 118, no. 3, pp. 686–692, 2011. View at Publisher · View at Google Scholar · View at Scopus
  81. V. S. Hoffmann, M. Baccarani, D. Lindoerfer et al., “The EUTOS prognostic score: review and validation in 1288 patients with CML treated frontline with imatinib,” Leukemia, vol. 27, no. 10, pp. 2016–2022, 2013. View at Publisher · View at Google Scholar · View at Scopus
  82. S.-B. Cho, “Exploring features and classifiers to classify gene expression profiles of acute leukemia,” International Journal of Pattern Recognition and Artificial Intelligence, vol. 16, no. 7, pp. 831–844, 2002. View at Publisher · View at Google Scholar · View at Scopus
  83. I. Inza, B. Sierra, R. Blanco, and P. Larrañaga, “Gene selection by sequential search wrapper approaches in microarray cancer class prediction,” Journal of Intelligent & Fuzzy Systems, vol. 12, no. 1, pp. 25–33, 2002. View at Google Scholar · View at Scopus
  84. A. Farag, “Computer Based Acute Leukemia Classification,” in Proceedings of the 2003 46th Midwest Symposium on Circuits and Systems, pp. 701–703, Cairo, Egypt. View at Publisher · View at Google Scholar
  85. M. E. Futschik, A. Reeve, and N. Kasabov, “Evolving connectionist systems for knowledge discovery from gene expression data of cancer tissue,” Artificial Intelligence in Medicine, vol. 28, no. 2, pp. 165–189, 2003. View at Publisher · View at Google Scholar · View at Scopus
  86. S.-B. Cho and H.-H. Won, “Data mining for GENE expression profiles from DNA microarray,” International Journal of Software Engineering and Knowledge Engineering, vol. 13, no. 6, pp. 593–608, 2003. View at Publisher · View at Google Scholar · View at Scopus
  87. V. Marohnic, Z. Debeljak, and N. Bogunovic, “Mutual information based reduction of data mining dimensionality in gene expression analysis. Information Technology Interfaces,” in Proceedings of the 26th International Conference, pp. 7–10, 2004.
  88. J. F. McCarthy, K. A. Marx, P. E. Hoffman et al., “Applications of machine learning and high-dimensional visualization in cancer detection, diagnosis, and management,” Annals of the New York Academy of Sciences, vol. 1020, pp. 239–262, 2004. View at Publisher · View at Google Scholar · View at Scopus
  89. J. Rowland, “On genetic programming and knowledge discovery in transcriptome data,” in Proceedings of the 2004 Congress on Evolutionary Computation, pp. 158–165, Portland, OR, USA. View at Publisher · View at Google Scholar
  90. T. Markiewicz, S. Osowski, B. Marianska, and L. Moszczyński, “Automatic recognition of the blood cells of myelogenous leukemia using SVM,” in Proceedings of the International Joint Conference on Neural Networks, IJCNN 2005, pp. 2496–2501, August 2005. View at Publisher · View at Google Scholar · View at Scopus
  91. W. L. Tung and C. Quek, “GenSo-FDSS: a neural-fuzzy decision support system for pediatric ALL cancer subtype identification using gene expression data,” Artificial Intelligence in Medicine, vol. 33, no. 1, pp. 61–88, 2005. View at Publisher · View at Google Scholar · View at Scopus
  92. H. Nguyen, S. Ohn, J. Park, and K. Park, “Combined Kernel Function Approach in SVM for Diagnosis of Cancer,” in Advances in Natural Computation, vol. 3610 of Lecture Notes in Computer Science, pp. 1017–1026, Springer, Berlin, Germany, 2005. View at Publisher · View at Google Scholar
  93. V. P. Plagianakos, D. K. Tasoulis, and M. N. Vrahatis, “Computational intelligence techniques for acute leukemia gene expression data classification,” in Proceedings of the International Joint Conference on Neural Networks, IJCNN 2005, pp. 2469–2474, August 2005. View at Publisher · View at Google Scholar · View at Scopus
  94. F. Li and Y. Yang, “Analysis of recursive gene selection approaches from microarray data,” Bioinformatics, vol. 21, no. 19, pp. 3741–3747, 2005. View at Publisher · View at Google Scholar
  95. W. Jinlian, L. Jiangeng, and R. Xiaogang, “Mining leukemia gene association structure with DNA microarray,” in Proceedings of the 2005 International Conference on Neural Networks and Brain Proceedings, ICNNB'05, pp. 695–701, October 2005. View at Scopus
  96. F. Diaz, F. Fdez-Riverola, D. Glez-Pena, and J. M. Corchado, “Using fuzzy patterns for gene selection and data reduction on microarray data,” in Intelligent Data Engineering and Automated Learning - Ideal, E. Corchado, H. Yin, V. Botti, and C. Fyfe, Eds., Lecture Notes in Computer Science, pp. 1087–94, 2006.
  97. C. Feng and W. Lipo, “A Novel Approach Searching for Discriminative Gene Sets. Systems, Man and Cybernetics,” in Proceeding of the 2006 SMC '06 IEEE International Conference, pp. 8–11, 2006.
  98. H. Nguyen and S. Ohn, “DRFE: Dynamic Recursive Feature Elimination for Gene Identification Based on Random Forest,” in Neural Information Processing, vol. 4234 of Lecture Notes in Computer Science, pp. 1–10, Springer, Berlin, Germany, 2006. View at Publisher · View at Google Scholar
  99. W. Shulin, C. Huowang, W. Ji, and Z. Dingxing, “Molecular Diagnosis of Tumor Based on Independent Component Analysis and Support Vector Machines. Computational Intelligence and Security, 2006 International Conference on,” in Proceedings of the Computational Intelligence and Security, 2006 International Conference, 2006.
  100. Y. Chen, M. Dong, and M. Rege, “Gene expression clustering: A novel graph partitioning approach,” in Proceedings of the 2007 International Joint Conference on Neural Networks, IJCNN 2007, pp. 1542–1547, August 2007. View at Publisher · View at Google Scholar · View at Scopus
  101. M. Perez, D. M. Rubin, L. E. Scott, T. Marwala, and W. Stevens, “A Hybrid Fuzzy-SVM classifier, applied to gene expression profiling for automated leukaemia diagnosis,” in Proceedings of the 2008 IEEE 25th Convention of Electrical and Electronics Engineers in Israel, IEEEI 2008, pp. 41–45, December 2008. View at Publisher · View at Google Scholar · View at Scopus
  102. R. Avogadri, M. Brioschi, F. Ferrazzi, M. Re, A. Beghini, and G. Valentini, “A stability-based algorithm to validate hierarchical clusters of genes,” International Journal of Knowledge Engineering and Soft Data Paradigms, vol. 1, no. 4, p. 318, 2009. View at Publisher · View at Google Scholar
  103. A. Chaiboonchoe, S. Samarasinghe, and D. Kulasiri, “Using emergent clustering methods to analyse short time series gene expression data from childhood leukemia treated with glucocorticoids,” in Proceedings of the 18th World IMACS Congress and International Congress on Modelling and Simulation: Interfacing Modelling and Simulation with Mathematical and Computational Sciences, MODSIM09, pp. 741–747, July 2009. View at Scopus
  104. D. Glez-Peña, F. Díaz, F. Fdez-Riverola, J. R. Méndez, and J. M. Corchado, “Fuzzy patterns and GCS networks to clustering gene expression data,” Studies in Fuzziness and Soft Computing, vol. 242, pp. 103–125, 2009. View at Publisher · View at Google Scholar · View at Scopus
  105. Y. He and S. C. Hui, “Exploring ant-based algorithms for gene expression data analysis,” Artificial Intelligence in Medicine, vol. 47, no. 2, pp. 105–119, 2009. View at Publisher · View at Google Scholar · View at Scopus
  106. A. Mukhopadhyay, U. Maulik, and S. Bandyopadhyay, “Unsupervised cancer classification through SVM-boosted multiobjective fuzzy clustering with majority voting ensemble,” in Proceedings of the 2009 IEEE Congress on Evolutionary Computation, CEC 2009, pp. 255–261, May 2009. View at Publisher · View at Google Scholar · View at Scopus
  107. A. Torkaman, N. M. Charkari, M. Aghaeipour, and E. Hajati, “A recommender system for detection of leukemia based on cooperative game,” in Proceedings of the 2009 17th Mediterranean Conference on Control and Automation (MED), pp. 1126–1130, Thessaloniki, Greece, June 2009. View at Publisher · View at Google Scholar
  108. Z. Zheng, S. Sharma, N. Agarwal, and L. Huan, “Integrating Knowledge in Search of Biologically Relevant Genes,” in Proceedings of the Data Mining Workshops, 2009 ICDMW '09 IEEE International Conference, W. Jiangxin and C. Yung, Eds., 2009.
  109. A. M. Mehdi, M. S. Sehgal, A. Zayegh, R. Begg, and A. Manan, “K-means clustering on 3rd order polynomial based normalization of Acute Myeloid Leukemia (AML) and Acute Lymphocyte Leukemia (ALL),” in Proceedings of the 2009 3rd International Conference on Electrical Engineering, ICEE 2009, April 2009. View at Publisher · View at Google Scholar · View at Scopus
  110. C. Porzelius, M. Johannes, H. Binder, and T. Beissbarth, “Leveraging external knowledge on molecular interactions in classification methods for risk prediction of patients,” Biometrical Journal, vol. 53, no. 2, pp. 190–201, 2011. View at Publisher · View at Google Scholar · View at MathSciNet
  111. J. Chen, D. Li, B. Zhang, Z. Wang, Y. Wang, and Q. Zheng, “Notice of Retraction Alternol Inhibits Proliferation and Induces Apoptosis in Human Leukemia HL-60 Cells,” in Proceedings of the 2011 5th International Conference on Bioinformatics and Biomedical Engineering, pp. 10–12, 2011.
  112. J. A. Gonzalez, I. Olmos, L. Altamirano et al., “Leukemia identification from bone marrow cells images using a machine vision and data mining strategy,” Intelligent Data Analysis, vol. 15, no. 3, pp. 443–462, 2011. View at Publisher · View at Google Scholar · View at Scopus
  113. D. L. Tong and A. C. Schierz, “Hybrid genetic algorithm-neural network: Feature extraction for unpreprocessed microarray data,” Artificial Intelligence in Medicine, vol. 53, no. 1, pp. 47–56, 2011. View at Publisher · View at Google Scholar · View at Scopus
  114. P. S. Chauhan, R. Ihsan, A. K. Mishra et al., “High order interactions of xenobiotic metabolizing genes and P53 codon 72 polymorphisms in acute leukemia,” Environmental and Molecular Mutagenesis, vol. 53, no. 8, pp. 619–630, 2012. View at Publisher · View at Google Scholar · View at Scopus
  115. H. J. Escalante, M. Montes-y-Gómez, J. A. González et al., “Acute leukemia classification by ensemble particle swarm model selection,” Artificial Intelligence in Medicine, vol. 55, no. 3, pp. 163–175, 2012. View at Publisher · View at Google Scholar · View at Scopus
  116. K. Y. Yeung, T. A. Gooley, A. Zhang, A. E. Raftery, J. P. Radich, and V. G. Oehler, “Predicting relapse prior to transplantation in chronic myeloid leukemia by integrating expert knowledge and expression data,” Bioinformatics, vol. 28, no. 6, Article ID bts059, pp. 823–830, 2012. View at Publisher · View at Google Scholar · View at Scopus
  117. T. Manninen, H. Huttunen, P. Ruusuvuori, and M. Nykter, “Leukemia Prediction Using Sparse Logistic Regression,” PLoS ONE, vol. 8, no. 8, Article ID e72932, 2013. View at Publisher · View at Google Scholar · View at Scopus
  118. A. A. El-Nasser, M. Shaheen, and H. El-Deeb, “Enhanced leukemia cancer classifier algorithm,” in Proceedings of the 2014 Science and Information Conference, SAI 2014, pp. 422–429, August 2014. View at Publisher · View at Google Scholar · View at Scopus
  119. V. Singhal and P. Singh, “Correlation based feature selection for diagnosis of acute lymphoblastic leukemia,” in Proceedings of the 3rd ACM International Symposium on Women in Computing and Informatics (WCI '15), pp. 5–9, Kochi, India, August 2015. View at Publisher · View at Google Scholar
  120. D. Yao, J. Yang, X. Zhan, X. Zhan, and Z. Xie, “A novel random forests-based feature selection method for microarray expression data analysis,” International Journal of Data Mining and Bioinformatics, vol. 13, no. 1, pp. 84–101, 2015. View at Publisher · View at Google Scholar · View at Scopus
  121. J. Rawat, A. Singh, H. S. Bhadauria, and J. Virmani, “Computer Aided Diagnostic System for Detection of Leukemia Using Microscopic Images,” in Proceedings of the 4th International Conference on Eco-friendly Computing and Communication Systems, ICECCS 2015, pp. 748–756, December 2015. View at Publisher · View at Google Scholar · View at Scopus
  122. S. Kar, K. D. Sharma, and M. Maitra, “Gene selection from microarray gene expression data for classification of cancer subgroups employing PSO and adaptive K-nearest neighborhood technique,” Expert Systems with Applications, vol. 42, no. 1, pp. 612–627, 2015. View at Publisher · View at Google Scholar · View at Scopus
  123. J. Li, Y. Wang, Y. Cao, and C. Xu, “Weighted doubly regularized support vector machine and its application to microarray classification with noise,” Neurocomputing, vol. 173, pp. 595–605, 2016. View at Publisher · View at Google Scholar · View at Scopus
  124. A. K. Dwivedi, “Artificial neural network model for effective cancer classification using microarray gene expression data,” Neural Computing and Applications, pp. 1–10, 2016. View at Publisher · View at Google Scholar · View at Scopus
  125. S. Krappe, T. Wittenberg, T. Haferlach, and C. Münzenmayer, “Automated morphological analysis of bone marrow cells in microscopic images for diagnosis of leukemia: Nucleus-plasma separation and cell classification using a hierarchical tree model of hematopoesis,” in Proceedings of the Medical Imaging 2016: Computer-Aided Diagnosis, March 2016. View at Publisher · View at Google Scholar · View at Scopus
  126. R. Ocampo-Vega, G. Sanchez-Ante, M. A. De Luna, R. Vega, L. E. Falcón-Morales, and H. Sossa, “Improving pattern classification of DNA microarray data by using PCA and Logistic Regression,” Intelligent Data Analysis, vol. 20, no. 1, pp. S53–S67, 2016. View at Publisher · View at Google Scholar · View at Scopus
  127. B. Rajwa, P. K. Wallace, E. A. Griffiths, and M. Dundar, “Automated Assessment of Disease Progression in Acute Myeloid Leukemia by Probabilistic Analysis of Flow Cytometry Data,” IEEE Transactions on Biomedical Engineering, vol. 64, no. 5, pp. 1089–1098, 2017. View at Publisher · View at Google Scholar
  128. W. Ni, B. Hu, C. Zheng et al., “Automated analysis of acute myeloid leukemia minimal residual disease using a support vector machine,” Oncotarget, vol. 7, no. 44, pp. 71915–71921, 2016. View at Publisher · View at Google Scholar · View at Scopus
  129. D. Milojkovic, E. Nicholson, J. F. Apperley et al., “Early prediction of success or failure of treatment with second-generation tyrosine kinase inhibitors in patients with chronic myeloid leukemia,” Haematologica, vol. 95, no. 2, pp. 224–231, 2010. View at Publisher · View at Google Scholar · View at Scopus
  130. D. White, V. Saunders, A. B. Lyons et al., “In vitro sensitivity to imatinib-induced inhibition of ABL kinase activity is predictive of molecular response in patients with de novo CML,” Blood, vol. 106, no. 7, pp. 2520–2526, 2005. View at Publisher · View at Google Scholar · View at Scopus
  131. D. L. White and T. P. Hughes, “Predicting the response of CML patients to tyrosine kinase inhibitor therapy,” Current Hematologic Malignancy Reports, vol. 4, no. 2, pp. 59–65, 2009. View at Publisher · View at Google Scholar · View at Scopus
  132. D. L. White, V. A. Saunders, P. Dang et al., “Most CML patients who have a suboptimal response to imatinib have low OCT-1 activity: Higher doses of imatinib may overcome the negative impact of low OCT-1 activity,” Blood, vol. 110, no. 12, pp. 4064–4072, 2007. View at Publisher · View at Google Scholar · View at Scopus
  133. D. L. White, P. Dang, J. Engler et al., “Functional activity of the OCT-1 protein is predictive of long-term outcome in patients with chronic-phase chronic myeloid leukemia treated with imatinib,” Journal of Clinical Oncology, vol. 28, no. 16, pp. 2761–2767, 2010. View at Publisher · View at Google Scholar · View at Scopus
  134. S. Branford, D. T. Yeung, D. M. Ross et al., “Early molecular response and female sex strongly predict stable undetectable BCR-ABL1, the criteria for imatinib discontinuation in patients with CML,” Blood, vol. 121, no. 19, pp. 3818–3824, 2013. View at Publisher · View at Google Scholar · View at Scopus
  135. K. Sweet, L. Zhang, and J. Pinilla-Ibarz, “Biomarkers for determining the prognosis in chronic myelogenous leukemia,” Journal of Hematology and Oncology, vol. 6, no. 1, article 54, 2013. View at Publisher · View at Google Scholar · View at Scopus
  136. W. Prejzner, “Relationship of the BCR gene breakpoint and the type of BCR/ABL transcript to clinical course, prognostic indexes and survival in patients with chronic myeloid leukemia,” Medical Science Monitor, vol. 8, no. 5, pp. BR193–BR197, 2002. View at Google Scholar · View at Scopus
  137. D. Verma, H. M. Kantarjian, D. Jones et al., “Chronic myeloid leukemia (CML) with P190BCR-ABL: analysis of characteristics, outcomes, and prognostic significance,” Blood, vol. 114, no. 11, pp. 2232–2235, 2009. View at Publisher · View at Google Scholar · View at Scopus
  138. J.-Z. Xu and C.-W. Wong, “Hunting for robust gene signature from cancer profiling data: Sources of variability, different interpretations, and recent methodological developments,” Cancer Letters, vol. 296, no. 1, pp. 9–16, 2010. View at Publisher · View at Google Scholar · View at Scopus
  139. Y.-J. Fan and W. A. Chaovalitwongse, “Optimizing feature selection to improve medical diagnosis,” Annals of Operations Research, vol. 174, no. 1, pp. 169–183, 2010. View at Publisher · View at Google Scholar · View at Scopus
  140. Z. Chen, J. Li, L. Wei, W. Xu, and Y. Shi, “Multiple-kernel SVM based multiple-task oriented data mining system for gene expression data analysis,” Expert Systems with Applications, vol. 38, no. 10, pp. 12151–12159, 2011. View at Publisher · View at Google Scholar · View at Scopus
  141. E. J. Yeoh, M. E. Ross, S. A. Shurtleff et al., “Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling,” Cancer Cell, vol. 1, no. 2, pp. 133–143, 2002. View at Publisher · View at Google Scholar · View at Scopus
  142. A. Mukhopadhyay, U. Maulik, and S. Bandyopadhyay, “Refining genetic algorithm based fuzzy clustering through supervised learning for unsupervised cancer classification,” Lecture Notes in Computer Science (including subseries Lecture Notes in Artificial Intelligence and Lecture Notes in Bioinformatics), vol. 5483, pp. 191–202, 2009. View at Publisher · View at Google Scholar · View at Scopus
  143. J.-H. Cho, D. Lee, H. P. Jin, K. Kim, and I.-B. Lee, “Optimal approach for classification of acute leukemia subtypes based on gene expression data,” Biotechnology Progress, vol. 18, no. 4, pp. 847–854, 2002. View at Publisher · View at Google Scholar · View at Scopus
  144. Z. Chen, J. Li, and L. Wei, “A multiple kernel support vector machine scheme for feature selection and rule extraction from gene expression data of cancer tissue,” Artificial Intelligence in Medicine, vol. 41, no. 2, pp. 161–175, 2007. View at Publisher · View at Google Scholar · View at Scopus
  145. M. Baccarani, G. Saglio, J. Goldman et al., “Evolving concepts in the management of chronic myeloid leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet,” Blood, vol. 108, no. 6, pp. 1809–1820, 2006. View at Publisher · View at Google Scholar · View at Scopus
  146. T. Hughes and S. Branford, “Molecular monitoring of BCR-ABL as a guide to clinical management in chronic myeloid leukaemia,” Blood Reviews, vol. 20, no. 1, pp. 29–41, 2006. View at Publisher · View at Google Scholar · View at Scopus
  147. M. Baccarani, G. Gugliotta, F. Castagnetti, S. Soverini, and G. Rosti, “A Review and an Update of European LeukemiaNet Recommendations for the Management of Chronic Myeloid Leukemia,” in Chronic Myeloid Leukemia, Hematologic Malignancies, pp. 55–69, Springer International Publishing, Cham, 2016. View at Publisher · View at Google Scholar
  148. S. L. Noble, E. Sherer, R. E. Hannemann, D. Ramkrishna, T. Vik, and A. E. Rundell, “Using adaptive model predictive control to customize maintenance therapy chemotherapeutic dosing for childhood acute lymphoblastic leukemia,” Journal of Theoretical Biology, vol. 264, no. 3, pp. 990–1002, 2010. View at Publisher · View at Google Scholar · View at MathSciNet · View at Scopus
  149. L. M. Fagan and E. H. Shortliffe, The Future of Computer Applications in Biomedicine. Biomedical Informatics Computer Applications in Health Care and Biomedicine, Health Informatics, Springer, New York, NY, USA, 3rd edition, 2006.
  150. J. A. Cruz and D. S. Wishart, “Applications of machine learning in cancer prediction and prognosis,” Cancer Informatics, vol. 2, pp. 59–77, 2006. View at Google Scholar · View at Scopus